MISC has just wrapped production on a series of films in collaboration with City Of Hope, to promote the National Cancer Institute's groundbreaking research initiative: offering comprehensive genetic testing to every patient. City of Hope is also offering to sequence the genome of tumors for patients, in order to provide personalized treatment plans.

These films will educate patients and their families about why this testing is necessary for clinical care and why it is crucial for research purposes. The films were developed in collaboration with researchers at City of Hope, including Dr. Steven Gruber.

In order to reach the broadest range of City of Hope constituents, the series of films are in English, Spanish, and Mandarin. The films were produced by MISC Director Michael Taylor and directed by SCA alumnus John Berardo.

“With this film we are given the opportunity as filmmakers to change the overwhelming process for many patients receiving cancer care and help them better understand their treatment,” said Berardo. “To be able to direct such a life-touching project is the reason I will always come back to make movies with USCMISC.”

Filming on location at the City of Hope hospital during the COVID-19 pandemic presented many challenges, but the MISC team, with the help of Covid Compliance officers and through the generosity of the City of Hope staff, were able to make a compelling series of shorts that will ultimately improve patient outcomes.

Established in 1913, City of Hope is a National Cancer Institute and is a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols. City of Hope has been ranked among the nation’s best hospitals for cancer treatment by US News & World Report for over a decade.

You can learn more about City of Hope at https://www.cityofhope.org/

Articles

Behind The scenes